THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION
Yazar
Zhu, Z.
Karakas, Zeynep
Galanello, R.
Habr, D.
Cappellini, M.
Taher, A.
Porter, J.
Viprakasit, V.
Kattamis, A.
Chuncharunee, S.
Sutcharitchan, P.
Siritanaratkul, N.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]